Canada markets open in 5 hours 54 minutes
  • S&P/TSX

    +44.29 (+0.22%)
  • S&P 500

    +21.65 (+0.51%)
  • DOW

    +68.61 (+0.20%)

    -0.0001 (-0.02%)

    +0.02 (+0.03%)

    +1,384.70 (+3.42%)
  • CMC Crypto 200

    +23.98 (+3.02%)

    +2.80 (+0.16%)
  • RUSSELL 2000

    +9.85 (+0.43%)
  • 10-Yr Bond

    0.0000 (0.00%)
  • NASDAQ futures

    +15.75 (+0.11%)

    -1.63 (-9.11%)
  • FTSE

    +8.39 (+0.12%)
  • NIKKEI 225

    -9.24 (-0.03%)

    +0.0001 (+0.01%)

Immuno-Oncology Assays Market by Product & Service, Technology, Cancer Indications and Application - Global Forecast to 2026 -

·3 min read

The "Immuno-Oncology Assays Market by Product & Service (Consumables, Instruments, Software), Technology (PCR, NGS, Immunoassay), Cancer Indications (Lung, Breast, Colorectal, Bladder, Melanoma), Application (Research, Diagnostics) - Global Forecast to 2026" report has been added to's offering.

The global immuno-oncology assays market is projected to reach USD 7.9 billion by 2026 from USD 4.4 billion in 2021, at a CAGR of 12.5% during the forecast period.

Market growth is driven by factors such as the growing significance of companion diagnostics in drug development and rising incidence of cancer and growing adoption of targeted therapies. On the other hand, the requirement of high capital investments and low cost-benefit ratio and the unfavorable regulatory and reimbursement scenario are the major factors hampering the growth of this market.

The consumables segment accounted for the highest growth rate in the immuno-oncology assays market, by product & service, during the forecast period

The immuno-oncology assays market is segmented into consumables, instruments, and software & services based on product & service. In 2020, the consumables segment accounted for the highest growth rate in the immuno-oncology assays market. The requirement of consumables in large numbers as compared to instruments is the major factor contributing to the growth of this segment.

The research applications segment accounted for the highest CAGR

Based on application, the immuno-oncology assays market is segmented into research applications and clinical diagnostics. In 2020, the research applications segment accounted for the highest growth rate. This can be attributed to the rising prominence of biomarker-based drug development.

Asia Pacific: The fastest-growing region immuno-oncology assays market

The global immuno-oncology assays market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period. Growth in this region is expected to be centered on China and Japan. Factors such as the growing number of CROs in the region and the increasing awareness about the early detection of cancer are driving the growth of the immuno-oncology assays market in this region.

Market Dynamics


  • Rising Incidence of Cancer and Growing Adoption of Targeted Therapies

  • Increased Demand for Personalized Medicine


  • Requirement of High Capital Investments and Low Cost-Benefit Ratio

  • Unfavorable Regulatory and Reimbursement Scenario

  • High Cost of Immunotherapy


  • Emerging Markets Offer Lucrative Opportunities

  • Growing Significance of Companion Diagnostics


  • Low Awareness of Cancer Immunotherapy

Companies Mentioned

  • Abbott Laboratories, Inc.

  • Agilent Technologies, Inc.

  • Asuragen, Inc.

  • Bio-Rad Laboratories, Inc.

  • Biomerieux Sa

  • Charles River Laboratories, Inc.

  • Creative Biolabs

  • F. Hoffmann-La Roche Ltd.

  • Guardant Health, Inc.

  • HTG Molecular Diagnostics, Inc.

  • Illumina, Inc.

  • Invivoscribe, Inc.

  • Merck Millipore

  • Meso Scale Diagnostics, LLC.

  • Myriad Genetics, Inc.

  • Nanostring Technologies, Inc.

  • NMI Technologietransfer GmbH

  • Olink

  • Perkinelmer, Inc.

  • Qiagen N.V.

  • Reachbio LLC

  • Sartorius Ag

  • Seegene Inc.

  • Thermo Fisher Scientific, Inc.

For more information about this report visit

View source version on

Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting